SHARE

Join Us at Chemspec Europe 2025 in June Join Us at Chemspec Europe 2025 in June
19.05.2025

Join Us at Chemspec Europe 2025 in June

Join Us at Chemspec Europe 2025 in June

As a benchmark exhibition in Europe, Chemspec Europe 2025 focuses on customized chemical solutions and innovative technologies. With its highly specialized positioning, the exhibition has become a core platform for global industry elites to connect resources and expand business networks. The exhibition, which covers the entire industry chain of pharmaceuticals, electronic chemicals, agricultural chemicals and other fields, is not only a hub for technology and knowledge exchange, but also an efficient channel for companies to explore the international market.

Porton Pharma Solutions is a global company with over 4,200 employees and R&D and GMP-compliant manufacturing facilities across the US, EU, and China. It provides customer-centric, innovative, and reliable CDMO solutions for Small Molecules, Tides, Biologics and Conjugates (such as ADCs, AOCs, PDCs, RDCs, etc.), as well as Advanced Therapy Medicinal Products, from pre-clinical to commercial stages. The grand opening of Chemspec Europe 2025 undoubtedly provides an excellent platform for industry enterprises to showcase and exchange ideas. In view of this, Porton will unveil its booth at Booth 4T29 in the Koelnmesse in Germany on June 4-5, 2025, focusing on demonstrating its full-life cycle service capabilities for the research and development and production of small molecule innovative drugs.

- State-of-the-art Technology Platform

Join Us at Chemspec Europe 2025 in June

- Comprehensive CDMO Solutions

We provide comprehensive pharmaceutical API development services across all lifecycle stages - from preclinical research to IND support, and Phase I to Phase III studies, as well as commercial technology transfer and manufacture.

- Case Studies

Rapid Launch of Innovative Drugs from Preclinical to Commercialization in 18 Months

Porton cordially invites worldwide collaborators to explore emerging opportunities in small molecule drug development through synergistic partnerships. We anticipate engaging with industry peers to discuss transformative trends and leverage cutting-edge technologies to pioneer new paradigms in pharmaceutical innovation. Schedule your exclusive session @ Booth 4T29,our scientists and BD team are eager to meet you in person.

Join Us at Chemspec Europe 2025 in June

SHARE

Join Us at Chemspec Europe 2025 in June Join Us at Chemspec Europe 2025 in June
Join Us at Chemspec Europe 2025 in June Porton's Near-Term Target Validated by the SBTi Porton Wins Outsourced Pharma 2025 CDMO Leadership Award Porton to Showcase Cutting-edge Innovations at BIO-Europe Spring 2025 Join Porton at Leading Industry Conferences to Explore Innovations and Network with Experts Porton Has Been Invited to the China–Slovenia Business and Investment Forum and Had a Friendly Meeting with Slovenian Officials. Porton’s New Modality Capacity Upgrade Ceremony Successfully Held Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar Driving innovation and excellence in the CDMO industry, Porton Pharma Solutions 2024 CPHI Europe Review Technical Enability | Porton’s Team of Global Chemical Engineering and Technology Published Breakthrough Results in Crystal Growth & Design and reported them at the 2024 Crystal Engineering Gordon Research Conference Keep hope alive! We invite you to stay tuned to DMD Porton Experts Invited To Participate In The University Of Perugia Master PRO-API Program, Aiding In The Training Of Green Process Chemistry Professionals Porton Will Be Participating In Biotech Outsourcing Strategies Events This June Proton At CPhI North America Again Porton 2023 ESG Report Upcoming Porton Shows In Europe And The USA:Shaping Our Future Together Porton Makes Debut At DCAT Week 2024 To Jointly Promote Industry Development Join Our Founder And CEO @ DCAT Week Porton Pharma Solutions Joined The SBTi To Drive Climate Action Farewell To 2023, And WE Are Sailing Forward To 2024 The Pharma Crystallization Summit (PCS) Is Held Annually To Bring Together Developers Of New Medicines With Crystallization Challenges And The Crystallization Experts (Solution Providers) In The Industry And Academia. Porton Gets Improved In The 2023 S&P Global ESG Score Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization And Drug Product Development Services Pharma Digital Intelligence Summit Will Be Held On 5th, September, 2023 [Important Notice] Porton Announcement Regarding The Change Of Email Domain Porton Unveils Its Small Molecule Platform Headquarters In Shanghai PORTON Starts Construction Of Its Facility For Antibodies And ADCs In Shanghai Porton At DCAT Week 2023: A Highly Successful And Strategic Event Porton Released 2022 CSR Report Porton Delivers Strong 2022 Performance With 127% Sales Growth Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score
News

Insights Unveiled: Delve into Our Global News Hub!

22.05.2024

Porton Pharma Solutions embark on the next frontier in Mengeš, Slovenia

  • Opening ceremony of the state-of-the-art research and development laboratories for active pharmaceutical ingredients, small molecules, of Porton in Mengeš

  • A donation of EUR 20,000.00 to the municipality of Mengeš for the restoration of a flooded kindergarten

  • New jobs and further growth in the field of API's small molecules in Slovenia, Mengeš

Read the news

Cookie settings

Your current status

Show details